However, AFP has limited sensitivity and specificity, particularly in early-stage HCC, and false elevations can occur in conditions such as active hepatic inflammation (e.g., viral hepatitis) or other liver masses like cholangiocarcinoma (25). Here, AFP is linked to cholangiocarcinoma.